ASX Market Close: Index dips slightly as AMP soars | August 8, 2024

Volatility remained the status quo as the ASX200 ended down 0.23%. The local bourse briefly touched into the green after lunch, but the mood was short-lived. The market almost immediately pared gains, sinking back into the red.

Exploring the causes and potential solutions to Australia's housing crisis

Real estate industry experts Owen Davis and Emma Slape join Bushy Martin to discuss the challenges and trends in Australia's housing market.

Provaris tells ASX non-binding MOUs are still material to share prices in somewhat fiery compliance response

ASX query response announcements are typically most read when companies get a speeding ticket, but one from hydrogen tanker company Provaris (ASX:PV1) on Thursday made for exciting reading.

Economists query RBA lack of action on sticky inflation amid global uncertainty

The Reserve Bank's decision this week was mostly in-line with expectations, given recent CPI data. But inflation pressures remain.

Cynata study shows efficacy of stem-cell therapy on chronic lung disease

Cynata Therapeutics Ltd has published a study examining the effect of its Cymerus therapy on idiopathic pulmonary fibrosis symptoms.

ASX Market Update: Miners weigh on bourse as AMP spikes | August 8, 2024

The ASX200 is proving less turbulent than futures predicted down 0.3%. This follows falls on Wall Street and continuing market volatility.

Joyce takes $9M renumeration hit, Qantas acknowledges 'significant reputational issues'

Qantas Airlines Ltd has released a Governance Review to examine failings by the company's board in the past 12 months.

'Nasal spray viagra' company LTR Pharma jumps 8% on second prescription under TGA access scheme

LTR Pharma (ASX:LTP) has announced its nasal spray 'viagra drug' SPONTAN has been prescribed by a Brisbane-based men's health expert under the drug regulator's Special Access Scheme (SAS).

Codeifai's QR code product integrated by pre-US-IPO darling Canva – but also announces $0.6M placement

Codeifai (ASX:CDE) has hit shareholders with a good-news-bad-news sandwich on Thursday, outlining a deal with Canva and a $0.6M placement on the same day.